Hjem › Myelofibrose › Michigan
Myelofibrose kliniske forsøg i Michigan
10 studier for Myelofibrose søger deltagere på steder i Michigan.
Byer i Michigan
Officiel studietekst (engelsk)
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
- University of Michigan, Ann Arbor
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT04176198A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
- START Midwest, LLC, Grand Rapids
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07469891Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- University of Michigan, Ann Arbor
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT05320198A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
- University of Michigan, Ann Arbor
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT06343805Quantitative MRI for Myelofibrosis
- University of Michigan Hospital, Ann Arbor
RekruttererObservationsstudie
Alder 18 til 99 · Alle køn · Opdateret 31. jul. 2026 · NCT01973881Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
- GSK Investigational Site, Ann Arbor
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 20. apr. 2026 · NCT06517875A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
- University of Michigan ( Site 6000), Ann Arbor
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 2. apr. 2026 · NCT06351631A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Karmanos Cancer Institute, Detroit
RekruttererFase 2
Alder 18 til 66 · Alle køn · Opdateret 17. mar. 2026 · NCT06859424SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Ann Arbor
- Massive Bio SYNERGY-AI site, Lansing
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
- University of Michigan Hospital, Ann Arbor
- Henry Ford Cancer Institute - Brigitte Harris Cancer Pavilion, Detroit
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2025 · NCT06479135Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.